In May 2017, the Food and Drug Administration (FDA) has concluded after two large clinical trials, that type 2 diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR) creates an increased risk of leg and foot amputations.
In May 2015, the FDA issued a warning about the Type 2 diabetes medication Invokana leading to a serious condition called ketoacidosis. This condition causes the body to produce high levels of blood acids also known as ketones, which may lead up to diabetic coma or death. Therefore, if a patient is suffering from ketoacidosis, they must immediately seek medical attention.
The FDA approved Invokana in August 2014. However, shortly thereafter the FDA began receiving reports of patients suffering from ketoacidosis, kidney problems and other health issues after taking Invokana. There has been no recall of Invokana, but the serious side effects from the drug have triggered numerous Invokana lawsuits from patients.
If you or any of your loved ones were diagnosed with ketoacidosis after taking Invokana, you may be eligible to file an Invokana lawsuit to hold the manufacturer accountable for your injuries. The Abbott Law Group P.A. is currently taking Invokana cases and will be able to help you file an Invokana lawsuit if your case meets the criteria. We have over thirty years or trial experience and our lawyers will help you obtain the maximum compensation to which you may be entitled. Call our toll free number or complete our online case evaluation form for a free consultation.
The FDA’s warning was a result of an investigation that revealed that there was a link between Invokana and ketoacidosis. Invokana is manufactured by Mitsubishi Tanabe Pharma and is marketed by Janssen Pharmaceuticals, Inc., an affiliate of Johnson & Johnson. The drug is a sodium-glucose co-transporter 2 (SGLT2) inhibitor, which is used to control blood sugar and increases the removal of glucose from the kidneys in type 2 diabetes patients. As diabetes can cause blindness, heart disease and a host of other serious health problems, the main purpose of the drug is to help restore the body’s response to insulin and control the intake of sugar in the body.
The FDA investigated 20 adverse event reports to conclude that Invokana caused ketoacidosis. Invokana was also found to increase the risks of kidney failure, heart attacks, and other cardiovascular diseases. Thus, the Agency quickly issued the safety announcement warning patients to seek immediate medical attention for any signs of ketoacidosis symptoms. The symptoms to look for include:
The FDA’s investigation and safety warning caused further angst in the health community. Thus, the number of Invokana lawsuits are increasing. The lawsuits are alleging that the manufacturer failed to warn about the high risks of taking Invokana. If the manufacturer had provided proper warning it would allow patients to have the option of taking an alternative medication. Also, while the manufacturer reported some side effects discovered during clinical trials, it neglected to report the more serious, life-threatening side effects. Therefore, if patients were more informed of the serious side effects, they would have performed the appropriate monitoring when taking the drug.
If you file an Invokana lawsuit, you may be eligible to receive compensation for past and future medical expenses, for pain and suffering, lost wages and other losses. Additionally, an Invokana lawsuit holds the manufacturer responsible for releasing a defective drug in the market, and discourages other drug companies from doing the same thing. With our longevity in trial practice, we know what it is like to go against drug companies like Mitsubishi Tanabe Pharma. So don’t delay and call us for a free Invokana lawsuit consultation today.